This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Parsons, R. G. Articles by Kowal, R. Search for Related Content PubMed PubMed Citation Articles by Parsons, R. G. Articles by Kowal, R.

Isolation and Identification of a Human Serum Fibronectin-like Protein Elevated during Malignant Disease¹

Biological Markers Program, National Cancer Institute-Frederick Cancer Research Center, Frederick, Maryland 21701

A human DNA-binding protein, designated MAD-2, has recently been found to be elevated in the serum from patients with malignant diseases. MAD-2 has been purified approximately 500-fold from peritoneal and pleural fluids collected from cancer patients. Immunodiffusion studies have indicated that MAD-2 is immunochemically identical to human plasma fibronectin. The purified material has been resolved by sodium dodecyl sulfate gel electrophoresis into two major protein chains with molecular weights in the range of 200,000 to 210,000 in either the presence or absence of disulfide bond-reducing agents. These results suggest that MAD-2 is a fibronectin fragment which has been generated through proteolysis. A quantitative assay system capable of detecting ng quantities of MAD-2 has been developed and used to verify the presence of elevated MAD-2 levels in DNA-binding protein fractions isolated from the serum of individuals with malignant diseases.

¹ Research supported by the National Cancer Institute under Contract N01-CO-75380 with Litton Bionetics, Inc.

² To whom requests for reprints should be addressed.

Received 5/21/79. Accepted 7/25/79.

This article has been cited by other articles:

				M. Sánchez-Carbayo, M. Urrutia, J. M. G. de Buitrago, and J. A. Navajo Evaluation of Two New Urinary Tumor Markers: Bladder Tumor Fibronectin and Cytokeratin 18 for the Diagnosis of Bladder Cancer Clin. Cancer Res., September 1, 2000; 6(9): 3585 - 3594. [Abstract] [Full Text]